Background: Protamine alters the inotropic responses to beta -adrenoceptor
stimulation, but its mechanism of action is not well-understood. Moreover,
its interaction with alpha -adrenoceptor stimulation and the lusitropic (re
laxation) response to beta -adrenoceptor stimulation remain unknown.
Methods: The effects of protamine (10 or 100 mug/ml) on the responses induc
ed by phenylephrine and isoproterenol were studied In rat left ventricular
papillary muscles. Inotropic and lusitropic effects were studied under low
and high loads. The authors also studied the interaction of protamine with
forskolin (50 mum) and dibutyryl 3',5'-cAMP (0.5 mm). Data are mean percent
age of baseline active force +/- SD.
Results: In control groups, phenylephrine (135 +/- 17%, P < 0.05) and isopr
oterenol (185 +/- 44%, P < 0.05) induced a positive inotropic effect. Isopr
oterenol induced positive lusitropic effects under low and high loads. Prot
amine abolished the inotropic responses to alpha- (102 +/- 23%, not signifi
cant) and beta -adrenoceptor stimulations (99 +/- 17%, not significant) but
did not modify the lusitropic responses to isoproterenol. Protamine abolis
hed the inotropic responses to forskolin (89 +/- 6 vs. 154 +/- 20%, P < 0.0
5) and markedly decreased that of dibutyryl 3',5'-cAMP (132 +/- 31 vs. 167
+/- 30%, P < 0.05) but did not modify their lusitropic responses.
Conclusions: Protamine abolished the inotropic responses to alpha- and beta
-adrenoceptor stimulations but preserved the lusitropic responses to beta
-adrenoceptor stimulation. Although protamine may act at several sites on t
he adrenoceptor stimulation cascade, one of its main sites of action is sit
uated downstream from cAMP-mediated phosphorylation.